2016-06-21 14:49:13 UTC

June 21, 2016

Join the AGA Center for Diagnostics and Therapeutics on Oct. 27 and 28, 2016, in Washington, DC, for the AGA Drug Development Conference: Clinical Endpoints in Upper GI Disorders.

Join the AGA Center for Diagnostics and Therapeutics on Oct. 27 and 28, 2016, in Washington, DC for the AGA Drug Development Conference: Clinical Endpoints in Upper GI Disorders. Share your voice in the discussion about unmet needs in the diagnosis and treatment of upper GI disorders, and learn from the leading experts about emerging biomarkers and therapies.

The 2016 AGA Drug Development Conference will focus on GERD, eosinophilic esophagitis, gastroparesis and functional dyspepsia. Sessions will introduce the clinical presentation and diagnosis of the disorders, discuss current therapeutic strategies, review clinical trial design and endpoints, and highlight future directions including emerging biomarkers and therapeutic targets.

Attendees will benefit from:

  • Increased knowledge of the scientific, clinical and regulatory challenges in drug and biomarker development for upper GI disorders.
  • New relationships and partnerships that can help spur therapeutic and diagnostic innovation in gastroenterology.

To learn more about the conference, visit ddc.gastro.org.

More on Dyspepsia / Non-Ulcer Dyspepsia